GMDA - Gamida Cell - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

70.28M

Cash

60.43M

Avg Qtr Burn

-19.76M

Short % of Float

8.30%

Insider Ownership

11.58%

Institutional Own.

26.49%

Qtr Updated

09/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Omidubicel (NiCord) Details Hematologic malignancies	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GDA-201 Details Multiple myeloma, Non-Hodgkin lymphoma	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.